Format

Send to

Choose Destination
Probiotics Antimicrob Proteins. 2017 Jun;9(2):123-130. doi: 10.1007/s12602-016-9230-1.

Probiotics Supplemented with Omega-3 Fatty Acids are More Effective for Hepatic Steatosis Reduction in an Animal Model of Obesity.

Author information

1
Bogomolets National Medical University, T. Shevchenko Boulevard, 13, Kiev, 01601, Ukraine. nazariikobyliak@gmail.com.
2
Taras Shevchenko National University of Kyiv, Volodymyrska Str., 64/13, Kiev, 01601, Ukraine.
3
Bogomolets National Medical University, T. Shevchenko Boulevard, 13, Kiev, 01601, Ukraine.

Abstract

Today probiotics have been suggested as a treatment for the prevention of NAFLD. Omega-3 fatty acid supplementation may have beneficial effects in regulating hepatic lipid metabolism, adipose tissue function and inflammation. The present study was designed to determine whether probiotics plus omega-3 are superior to probiotics alone on the monosodium glutamate (MSG)-induced NAFLD model in rats. We included 60 rats divided into four groups, 15 animals in each. Rats of group I were intact. Newborn rats of groups II-IV were injected with MSG. The III (Symbiter) group received 2.5 ml/kg of multiprobiotic "Symbiter" containing concentrated biomass of 14 probiotic bacteria genera. The IV (Symbiter-Omega) groups received "Symbiter-Omega" combination of probiotic biomass supplemented with flax and wheat germ oil (250 mg of each, concentration of omega-3 fatty acids 1-5 %). In both interventional groups reduction in total NAS score was observed. Supplementation of alive probiotic mixture with omega-3 fatty acids lead to 20 % higher decrease in steatosis score (0.73 ± 0.11 vs 0.93 ± 0.22, p = 0.848) and reduction by 16.6 % of triglycerides content in liver as compared to probiotic alone. Our study demonstrated more pronounced reduction in hepatic steatosis and hepatic lipid accumulation after treatment with combination of alive probiotics and omega-3 as compared to probiotics alone.

KEYWORDS:

Hepatic steatosis; Non-alcoholic fatty liver disease; Omega-3 fatty acids; Probiotics

PMID:
27660157
DOI:
10.1007/s12602-016-9230-1
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center